Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Patent 8466288 was granted and assigned to Vertex Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 6 Nov, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Nov, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer
0
Edits on 30 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C
0
Edits on 30 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 30 Nov, 2023
Edits made to:
Article (+306 characters)
Article

Patent abstract

The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Edits on 22 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2023
Edits made to:
Infobox (+17 properties)
Infobox
Patent Inventor Names
Albert Charles Pierce0
Alex Aronov0
Anne-Laure Grillot0
Arnaud Le Tiran0
David Messersmith0
Elaine B. Krueger0
Hardwin O'Dowd0
James A. Henderson0
Jian Wang0
Jingrong Cao0
Jon H. Come0
Philip N. Collier0
Robert J. Davies0
Ronald Lee Grey, Jr.0
Suganthini S. Nanthakumar0
Upul Keerthi Bandarage0
Yusheng Liao0
Edits on 17 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase US Patent 8466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Infobox
Patent Number
084662880
Patent Number
84662880
Edits on 26 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Vertex Pharmaceuticals
Vertex Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
084662880
Date of Patent
June 18, 2013
0
Patent Application Number
133498680
Date Filed
January 13, 2012
0
Patent Primary Examiner
‌
Timothy Thomas
0
Edits on 17 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 17 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Infobox
Is a
Patent
Patent
Current assignee
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08466288
Date of patent
June 18, 2013
Patent application number
13349868
Date Filed
January 13, 2012
Patent primary examiner
‌
Timothy Thomas

Find more entities like US Patent 8466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.